 Wai Cheung
|
|
| Title | Associate Project Scientist |
|---|
| Institution | University of California San Diego |
|---|
| Department | Pediatrics |
|---|
| Address | 9500 Gilman Drive #0630
La Jolla CA 92093
|
|---|
| Phone | 858-822-7957 |
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Mak RH, Cheung W, Solomon G, Gertler A. Preparation of Potent Leptin Receptor Antagonists and Their Therapeutic Use in Mouse Models of Uremic Cachexia and Kidney Fibrosis. Curr Pharm Des. 2018; 24(9):1012-1018. PMID: 29366406.
-
Cheung W, Hao S, Mak RH. Emerging roles of nuclear phosphatase SCP4 in CKD-associated muscle wasting. Kidney Int. 2017 Aug; 92(2):281-283. PMID: 28709594.
-
Mak RH, Cheung W. MicroRNA as Novel Exercise Mimetic for Muscle Wasting in CKD. J Am Soc Nephrol. 2017 Sep; 28(9):2557-2559. PMID: 28720683.
-
Oliveira EA, Cheung W, Toma KG, Mak RH. Muscle wasting in chronic kidney disease. Pediatr Nephrol. 2018 May; 33(5):789-798. PMID: 28508131.
-
Ji X, Li C, Ou Y, Li N, Yuan K, Yang G, Chen X, Yang Z, Liu B, Cheung W, Wang L, Huang R, Lan T. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-?B pathway. Mol Cell Endocrinol. 2016 Dec 05; 437:268-279. PMID: 27378149.
-
Tu J, Cheung W, Mak RH. Inflammation and nutrition in children with chronic kidney disease. World J Nephrol. 2016 May 06; 5(3):274-82. PMID: 27152263; PMCID: PMC4848150.
-
Cheung W, Cherqui S, Ding W, Esparza M, Zhou P, Shao J, Lieber RL, Mak RH. Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis. J Cachexia Sarcopenia Muscle. 2016 May; 7(2):152-64. PMID: 27493869; PMCID: PMC4864942.
-
Ding W, Cheung W, Mak RH. Impact of obesity on kidney function and blood pressure in children. World J Nephrol. 2015 May 06; 4(2):223-9. PMID: 25949935; PMCID: PMC4419131.
-
Mak RH, Cheung W, Gertler A. Exploiting the therapeutic potential of leptin signaling in cachexia. Curr Opin Support Palliat Care. 2014 Dec; 8(4):352-7. PMID: 25259544.
-
Lee B, Qiao L, Lu M, Yoo HS, Cheung W, Mak R, Schaack J, Feng GS, Chi NW, Olefsky JM, Shao J. C/EBPa regulates macrophage activation and systemic metabolism. Am J Physiol Endocrinol Metab. 2014 May 15; 306(10):E1144-54. PMID: 24691027; PMCID: PMC4025063.
-
Cheung W, Ding W, Gunta SS, Gu Y, Tabakman R, Klapper LN, Gertler A, Mak RH. A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice. J Am Soc Nephrol. 2014 Jan; 25(1):119-28. PMID: 24115476; PMCID: PMC3871780.
-
Cheung W, Mak RH. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease. Am J Physiol Renal Physiol. 2012 Nov 01; 303(9):F1315-24. PMID: 22914778; PMCID: PMC3518185.
-
Mak RH, Cheung W. MicroRNAs: a new therapeutic frontier for muscle wasting in chronic kidney disease. Kidney Int. 2012 Aug; 82(4):373-4. PMID: 22846810.
-
Cheung W, Mao P. Recent advances in obesity: genetics and beyond. ISRN Endocrinol. 2012; 2012:536905. PMID: 22474595; PMCID: PMC3313574.
-
Mak RH, Cheung W. Is ghrelin a biomarker for mortality in end-stage renal disease? Kidney Int. 2011 Apr; 79(7):697-9. PMID: 21403653.
-
Ziegler MG, Milic M, Sun P, Tang CM, Elayan H, Bao X, Cheung W, O'Connor DT. Endogenous epinephrine protects against obesity induced insulin resistance. Auton Neurosci. 2011 Jul 05; 162(1-2):32-4. PMID: 21354376; PMCID: PMC3111898.
-
Mak RH, Cheung W, Zhan JY, Shen Q, Foster BJ. Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol. 2012 Feb; 27(2):173-81. PMID: 21298504; PMCID: PMC3249542.
-
Cheung W, Zhan JY, Paik KH, Mak RH. The impact of inflammation on bone mass in children. Pediatr Nephrol. 2011 Nov; 26(11):1937-46. PMID: 21197596; PMCID: PMC3178021.
-
Cheung W, Mak RH. Ghrelin in chronic kidney disease. Int J Pept. 2010; 2010. PMID: 20721357; PMCID: PMC2915808.
-
Cheung W, Paik KH, Mak RH. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol. 2010 Apr; 25(4):711-24. PMID: 20111974.
-
Gayen JR, Saberi M, Schenk S, Biswas N, Vaingankar SM, Cheung W, Najjar SM, O'Connor DT, Bandyopadhyay G, Mahata SK. A novel pathway of insulin sensitivity in chromogranin A null mice: a crucial role for pancreastatin in glucose homeostasis. J Biol Chem. 2009 Oct 16; 284(42):28498-509. PMID: 19706599; PMCID: PMC2781393.
-
Cheung W, Mak RH. Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease. Kidney Int. 2009 Jul; 76(2):135-7. PMID: 19564855.
-
Cheung W, Rosengren S, Boyle DL, Mak RH. Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int. 2008 Jul; 74(2):180-6. PMID: 18432186.
-
Mak RH, Cheung W. Therapeutic strategy for cachexia in chronic kidney disease. Curr Opin Nephrol Hypertens. 2007 Nov; 16(6):542-6. PMID: 18089968.
-
Mak RH, Cheung W, Roberts CT. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res. 2008 Feb; 18(1):17-25. PMID: 17826224; PMCID: PMC2706146.
-
Cheung W, Kuo HJ, Markison S, Chen C, Foster AC, Marks DL, Mak RH. Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol. 2007 Sep; 18(9):2517-24. PMID: 17687077.
-
Mak RH, Cheung W. Adipokines and gut hormones in end-stage renal disease. Perit Dial Int. 2007 Jun; 27 Suppl 2:S298-302. PMID: 17556323.
-
Mak RH, Kuo HJ, Cheung W. Animal models of obesity-associated chronic kidney disease. Adv Chronic Kidney Dis. 2006 Oct; 13(4):374-85. PMID: 17045223.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|